Results 41 to 50 of about 2,302 (210)

ANTIHYPERTENSIVE AND VASOPROTECTIVE EFFECTS OF FOSINOPRILE IN PATIENTS WITH ARTERIAL HYPERTENSION

open access: yesМедицинский совет, 2018
Objective: evaluate antihypertensive and vasoprotective effects of fosinopril in patients with arterial hypertension with a high and very high risk of cardiovascular complications. Material and methods.
N. Yu. Grigorieva   +4 more
doaj   +1 more source

Effect of protease inhibitors on the intraerythrocytic development of Babesia microti and Babesia duncani, the causative agents of human babesiosis

open access: yesJournal of Eukaryotic Microbiology, Volume 72, Issue 2, March/April 2025.
Abstract Human babesiosis is a malaria‐like, tick‐borne infectious disease with a global distribution. Babesiosis is caused by intraerythrocytic, apicomplexan parasites of the genus Babesia. In the United States, human babesiosis is caused by Babesia microti and Babesia duncani.
Temitope Aderanti   +2 more
wiley   +1 more source

High performance liquid chromatographic method for simultaneous determination of fosinopril sodium and hydrochlorothiazide in tablets formulation [PDF]

open access: yes, 2006
Se ha desarrollado un método HPLC de fase inversa con detección de UV sencillo, específi co, exacto y preciso para la determinación de fosinopril sódico e hidroclorotiazida en formulaciones farmacéuticas. La solución de fármaco se preparó en fase móvil
Sutariya, V.B.   +2 more
core  

Evaluating chronopharmacological effectiveness of fosinopril and its combination with melatonin in elderly patients with hypertension and coronary artery disease

open access: yesМедицинский совет, 2014
High incidence of cardiovascular diseases globally, including arterial hypertension (AH) and coronary artery disease (CAD), as well as a considerable social impact made by the diseases and their complications, call for finding new ways to improve ...
O. A. Lednev
doaj   +1 more source

Drug‐Induced Liver Injury in Patients With Chronic Liver Disease

open access: yesLiver International, Volume 45, Issue 3, March 2025.
ABSTRACT Objective Drug‐induced liver injury (DILI) is a global problem and can develop from exposure to prescription or over‐the‐counter medications as well as herbal and dietary supplements. The diagnosis of DILI is clinically challenging, and liver injury can be severe leading to liver failure, death, or liver transplantation.
Marwan Ghabril   +2 more
wiley   +1 more source

Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria

open access: yes, 2008
Inflammation is an important factor in the development and progression of atherosclerosis. Observational studies have suggested that renin-angiotensin system inhibition might lower C-reactive protein (CRP).
van der Harst, Pim   +6 more
core   +1 more source

Datasheet1_Efficacy of fosinopril and amlodipine in pediatric primary hypertension: a single-center observational study.docx

open access: yes, 2023
ObjectiveFosinopril and amlodipine are commonly prescribed as first-line pharmacotherapeutic agents for pediatric hypertension, but there is a lack of comparative studies regarding the efficacy of these two drugs.
Wenquan Niu (118888)   +5 more
core   +1 more source

Genetic polymorphisms influencing antihypertensive drug responses

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 4, Page 929-950, February 2025.
Abstract Hypertension is a major contributor to cardiovascular disease and its associated morbidity and mortality. The low efficacy observed with some anti‐hypertensive therapies has been attributed partly to inter‐individual genetic variability. This paper reviews the major findings regarding these genetic variabilities that modulate responses to anti‐
Jana El Cheikh   +4 more
wiley   +1 more source

The role of fosinopril in the treatment and prevention of cardiovascular diseases

open access: yesМедицинский совет, 2015
In Russia, cardiovascular diseases account for 57% of deaths in the overall mortality. Arterial hypertension (AH) is one of the main risk factors (RF) for cardiovascular diseases (along with dyslipidemia, smoking, metabolic syndrome, diabetes mellitus ...
G. A. Baryshnikova
doaj   +1 more source

Fosinopril improves liver fibrosis by upregulating ACE2/Angiotensin-(1-7) axis activation in rats with nonalcoholic steatohepatitis [PDF]

open access: yes, 2012
The aim of this research was to evaluate the effect of the angiotensin converting enzyme (ACE) inhibitor fosinopril on liver fibrosis in rats with high fat diet (HFD) induced nonalcoholic steatohepatitis (NASH).
Xiao, Xiaoqiu   +8 more
core  

Home - About - Disclaimer - Privacy